Access the COVID-19 dashboard

Situation reports

A fortnightly update concerning the impact of and response to the COVID-19 pandemic in Gavi-supported countries.

Gavi's response

With COVID-19 now reported in almost all Gavi-eligible countries, the Vaccine Alliance is providing immediate funding to health systems, enabling countries to protect health care workers, perform vital surveillance and training, and purchase diagnostic tests.

Gavi and its Alliance partners are also working to maintain ongoing immunisation programmes, avoiding future deaths resulting from a range of preventable diseases including measles, yellow fever, polio, meningitis, pneumonia and diarrhoea.

Gavi is committed to securing a global response to COVID-19 that is effective and fair, using its unique expertise to help identify and rapidly accelerate development, production and delivery of COVID-19 vaccines so that anyone that needs them, gets them.

COVID-19 reprogramming (as of 19 May 2020)

200US$ million
immediately available for response
46reprogramming applications
59.1US$ million
reallocated for approved applications

Subscribe to our newsletter